Diabetes Mellitus, Type 2 Clinical Trial
— STBDOfficial title:
Obesity and Type 2 Diabetes - Raising the Issue of Weight Management in Primary Care (Small Talk Big Difference)
Verified date | November 2018 |
Source | NHS Greater Glasgow and Clyde |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To ensure that patients who are overweight or obese and have type 2 diabetes are identified,
receive personalised diabetes care, have the issue of weight raised and explained in a
non-judgemental manner by staff in primary care, and are referred on to weight management
services as appropriate ensuring equity of access across NHS Greater Glasgow and Clyde.
Specific aims of the whole project:
1. To improve GP/ primary care staff knowledge of the evidence base for the management of
diabetes when there is co-existing obesity and local care pathways
2. To increase GP/ primary care staff knowledge of and confidence in their role in raising
the issue of weight management,
3. To improve primary care referral rates of appropriate patients who are overweight or
obese and have type 2 diabetes, and are "ready to change" to NHS funded weight
management services
4. To improve patient uptake of and attendance at NHS funded weight management services NB
This is a service evaluation of a training programme being delivered by NHS Greater
Glasgow and Clyde Health Improvement. Full ethical approvals are being sought due to the
randomised design and so that results can be generalised and published.
Status | Completed |
Enrollment | 100 |
Est. completion date | November 1, 2018 |
Est. primary completion date | November 1, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - GP practices in NHS Greater Glasgow and Clyde which: - Have a contract for local enhanced services for long term conditions (Diabetes) - Have a unique clinical database (i.e. not shared with another practice) Exclusion Criteria: - "17c" practices (those with a separate contract for long term conditions) - Those practices with a database shared with another practice (8 practices in area) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | Glasgow Cardiovascular Research Centre | Glasgow | Scotland |
Lead Sponsor | Collaborator |
---|---|
NHS Greater Glasgow and Clyde | University of Glasgow |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Measure the effectiveness of an online training programme, practice implementation toolkit and face to face training for primary care staff | which will be measured as number of patient referrals and patient attendance at NHS funded weight management services | 12 months | |
Secondary | Implementation/ Normalization | NOMAD questionnaire will be used to ascertain how STBD impacts on primary care clinicians work | 12 months | |
Secondary | Percentage of diabetes reviews with recorded weight management discussion in LES template | percentage of diabetes review in primary care | 12 months | |
Secondary | Training uptake | Training uptake - online, face to face and experiential By practice By GP and practice Nurse By diabetes lead |
12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |